百利高 PRGO 深 滬
已收盤 09-05 16:00:00 美东时间
22.65
-0.640
-2.75%
華盛通- 最 高23.68
- 今 開23.22
- 成交量 314.39万股
- 最 低 22.28
- 昨 收 23.29
- 總市值 31.26亿
- 52周最高 30.06
- 市盈率 靜 --
- 換手率 2.28%
- 52周最低 20.74
- 委 比 96.74%
- 總股本 1.38亿
- 歷史最高 206.589
- 量 比 2.43
- 振 幅 6.01%
- 歷史最低 20.74
- 每 手 1
- 風險率 1.54%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多'Local 210 Calls Out Pharmaceutical Manufacturer For Trying To Slash Workers' Benefits; Members Of Teamsters Local 210 Are On Strike At Perrigo Company's Bronx Manufacturing Facilities' - Teamsters
https://teamster.org/2025/09/perrigo-teamsters-in-new-york-launch-strike/
09-06 03:03
Perrigo to Attend Barclays 18th Annual Global Consumer Staples Conference
DUBLIN, Aug. 20, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and ...
08-20 19:30
Missed Opt-Out Deadline Could Cost Investors Millions In Perrigo Fraud Suit
Perrigo faces a legal battle over whether major investor Sculptor can exit a securities class action years after missing the opt-out deadline amid $1 billion restatements.
08-14 02:28
美股大行评级 | DoorDash获上调目标价从230美元升至300美元； 摩根大通上调Shopify目标价从115美元升至179美元
今日重点评级关注：HC Wainwright & Co.：维持FibroGen"买入"评级，目标价从10美元升至43美元；摩根大通：维持Cogent Biosciences"超配"评级，目标价从29美元升至30美元
08-08 09:34
JP Morgan Maintains Overweight on Perrigo, Lowers Price Target to $35
JP Morgan analyst Chris Schott maintains Perrigo (NYSE:PRGO) with a Overweight and lowers the price target from $38 to $35.
08-08 05:19
SA Asks: How could higher India tariffs impact drug stocks?
India is a major supplier of prescription drugs, over-the-counter medications, and pharmaceutical ingredients to the United States. Recently, President Trump announced he intends to impose a 25% tari...
08-08 01:00
Perrigo shares are trading lower after the company reported worse-than-expected Q2 financial results.
Perrigo shares are trading lower after the company reported worse-than-expected...
08-06 20:22
Perrigo Affirms FY2025 Adj EPS Guidance of $2.90-$3.10 vs $3.04 Est; Affirms FY2025 Sales Guidance of $4.373B-$4.504B vs $4.426B Est
Fiscal 2025 OutlookThe Company reaffirms its fiscal year 2025 outlook. Reported and organic net sales growth are expected towards the lower end of their respective ranges, primarily due to infant formula industry
08-06 18:43
Perrigo Q2 Adj. EPS $0.57 Misses $0.59 Estimate, Sales $1.056B Miss $1.082B Estimate
Perrigo (NYSE:PRGO) reported quarterly earnings of $0.57 per share which missed the analyst consensus estimate of $0.59 by 3.88 percent. This is a 7.55 percent increase over earnings of $0.53 per share from the same
08-06 18:31
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
